Schaeffer's Top Stock Picks for '25

Abbott Labs' 15-Minute COVID-19 Test Gets FDA Approval

Baird called the new test a game changer

Digital Content Manager
Aug 27, 2020 at 11:24 AM
facebook X logo linkedin


The shares of Abbott Laboratories (NYSE:ABT) are trading at fresh highs this morning, up 7.2% at $110.64 after the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization to its COVID-19 portable antigen test. The test can deliver results within 15 minutes -- much shorter than the testing methods currently being used -- and will sell for $5. Abbott said it expects to ship 50 million tests one month from the beginning of October.  

One J.P. Morgan analyst chimed in, saying he believes the test will be vital for society to return to a sense of normalcy, adding that the shorter wait times will enable better tracking and spread prevention. Meanwhile, Baird called the test a game changer. The majority of brokerage firms covering the security are already quite optimistic, however. Of the 15 in coverage, 80% consider ABT a "buy" or better. 

This news has the options pits abuzz with activity, too. So far, 81,000 calls have crossed the tape, which is 24 times the intraday average, with volume running in its top annual percentile. Put volume has picked up too, with the 7,752 puts exchanged so far running at eight times the intraday average. The most popular contract is the weekly 9/4 12-strike call, where positions are being opened. This is followed by the weekly 8/28 120-strike call, where positions are also being opened. 

This tendency toward calls has been the norm, though. In the last 10 days, 3.93 calls were picked up for every put at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio sits in the 87th percentile of its annual range, suggesting a much healthier-than-usual appetite for bullish bets of late. 

A longer term look at ABT shows the equity has been steadily climbing into uncharted territory since late last month after springboarding off long-time support at the 100-day moving average. The 30-day has also given Abbott stock a boost, pushing it toward the 27.5% year-to-date gain that it currently boasts. 

ABT Aug 27

On a final note, traders might want to get in on ABT's surge while options are still relatively cheap. Abbott's Schaeffer's Volatility Index (SVI) of 25% sits higher than just 15% of readings from the past 12 months. This means options players are pricing in low volatility expectations at the moment.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?

 

 

(function(doc, script) { var js, fjs = doc.getElementsByTagName(script)[0], frag = doc.createDocumentFragment(), add = function(url, id) { if (doc.getElementById(id)) {return;} js = doc.createElement(script); js.src = url; id && (js.id = id); frag.appendChild( js ); }; // Google+ button //add('https://apis.google.com/js/platform.js', async="defer"); // Facebook SDK add('//connect.facebook.net/en_US/all.js#xfbml=1&appId=772755279557744', 'facebook-jssdk'); // Twitter SDK //add('//platform.twitter.com/widgets.js', charset='utf-8'); fjs.parentNode.insertBefore(frag, fjs); }(document, 'script'));